India considers opening Covid-19 boosters to all adults, says report

India's total infections now stand at more than 43 million, with 516,510 deaths.

Booster shot
The government is debating whether to provide boosters to everyone above 60 for free
Reuters New Delhi
2 min read Last Updated : Mar 22 2022 | 12:24 AM IST
India is considering making all adults eligible for booster doses of Covid-19 vaccine, two sources with knowledge of the matter said on Monday, as infections grow in some countries and some Indians find it hard to travel abroad without a third dose.

Only frontline workers and those older than 60 are currently allowed to take booster doses in India, whether free in government centres or paid for in private hospitals.

The government is debating whether to provide boosters to other groups for free, said one of the sources, who both sought anonymity as the government has yet to make a decision.

A health ministry spokesperson did not respond to a request for comment. The Serum Institute of India (SII), whose Covishield vaccine dominates India's immunisation programme, said on Monday it stopped the shot's production in December but still had a stock of 200 million doses. It has produced 1.9 billion doses in total. 

Its CEO Adar Poonawalla told CNBC-TV18 that they would restart production of the vaccine, a version of the AstraZeneca shot, if demand returned through boosters or any other way.

Health ministry, meanwhile, has urged states to boost Covid-19 surveillance measures, citing a resurgence in some parts of Asia and Europe. China and Italy have seen a recent rise in cases.

Infections in India, however, have fallen to their lowest in more than a year, with 1,549 new cases reported in the past 24 hours and 31 deaths. India’s total infections now stand at more than 43 million, with 516,510 deaths.

The country of about 1.4 billion people has administered 1.81 billion vaccine doses, more than 20 million as boosters. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineHealth Ministry

Next Story